<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Oncogene on CityU Wang Lab</title>
    <link>/categories/oncogene/</link>
    <description>Recent content in Oncogene on CityU Wang Lab</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Thu, 17 Nov 2016 13:07:31 +0200</lastBuildDate>
    
	<atom:link href="/categories/oncogene/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.</title>
      <link>/publications/1604onco_wx/</link>
      <pubDate>Thu, 17 Nov 2016 13:07:31 +0200</pubDate>
      
      <guid>/publications/1604onco_wx/</guid>
      <description>Author Fessler E, Jansen M, De Sousa E Melo F, Zhao L, Prasetyanti PR, Rodermond H, Kandimalla R, Linnekamp JF, Franitza M, van Hooff SR, de Jong JH, Oppeneer SC, van Noesel CJM, Dekker E, Stassi G, Wang X*, Medema JP*, and Vermeulen L*.
Oncogene 2016, doi:10.1038/onc.2016.134
Abstract Colorectal cancer (CRC) is a heterogeneous disease posing a challenge for accurate classification and treatment of this malignancy. There is no common genetic molecular feature that would allow for the identification of patients at risk for developing recurrences and thus selecting patients who would benefit from more stringent therapies still poses a major clinical challenge.</description>
    </item>
    
    <item>
      <title>A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.</title>
      <link>/blog/1604onco_wx/</link>
      <pubDate>Thu, 17 Nov 2016 13:07:31 +0200</pubDate>
      
      <guid>/blog/1604onco_wx/</guid>
      <description>Author Fessler E, Jansen M, De Sousa E Melo F, Zhao L, Prasetyanti PR, Rodermond H, Kandimalla R, Linnekamp JF, Franitza M, van Hooff SR, de Jong JH, Oppeneer SC, van Noesel CJM, Dekker E, Stassi G, Wang X*, Medema JP*, and Vermeulen L*.
Oncogene 2016, doi:10.1038/onc.2016.134
Abstract Colorectal cancer (CRC) is a heterogeneous disease posing a challenge for accurate classification and treatment of this malignancy. There is no common genetic molecular feature that would allow for the identification of patients at risk for developing recurrences and thus selecting patients who would benefit from more stringent therapies still poses a major clinical challenge.</description>
    </item>
    
  </channel>
</rss>